Analyst Activity – Barclays Lowers Its Price Target On NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD) to $90.00

ME Staff
-
0

Analyst Ratings For NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)

Today, Barclays lowered its price target on NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD) to $90.00 per share.

Some recent analyst ratings include

  • 5/2/2018-Leerink Swann Reiterated Rating of Market Perform.
  • 2/23/2018-Royal Bank of Canada Reiterated Rating of Buy.
  • 2/12/2018-Mizuho Reiterated Rating of Buy .
  • 2/8/2018-Citigroup Reiterated Rating of Buy .

Dividend information for NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)

NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD) pays an annual dividend of $2.28 with a yield of 3.14%.

Dividend History for NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)

  • On 5/1/2018 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.57 3.14% with an ex dividend date of which will be payable on 6/28/2018.
  • On 2/6/2018 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.57 3.02% with an ex dividend date of 3/15/2018 which will be payable on 3/29/2018.
  • On 10/26/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 2.7% with an ex dividend date of 12/14/2017 which will be payable on 12/28/2017.
  • On 7/26/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 2.78% with an ex dividend date of 9/14/2017 which will be payable on 9/28/2017.
  • On 5/2/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 3.09% with an ex dividend date of 6/14/2017 which will be payable on 6/29/2017.
  • On 2/7/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 3.11% with an ex dividend date of 3/14/2017 which will be payable on 3/30/2017.
  • On 11/1/2016 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.47 2.59% with an ex dividend date of 12/13/2016 which will be payable on 12/29/2016.

Recent Insider Trading Activity For NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD) has insider ownership of 1.16% and institutional ownership of 78.43%.

  • On 4/27/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $73.91 per share and the total transaction amounting to $431,117.03.
  • On 4/20/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $73.74 per share and the total transaction amounting to $430,125.42.
  • On 4/13/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $75.56 per share and the total transaction amounting to $440,741.48.
  • On 4/6/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $74.47 per share and the total transaction amounting to $434,383.51.
  • On 4/2/2018 John C Martin, Director, sold 50,000 with an average share price of $73.14 per share and the total transaction amounting to $3,657,000.00.
  • On 3/23/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $75.02 per share and the total transaction amounting to $437,591.66.
  • On 3/16/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $80.09 per share and the total transaction amounting to $467,164.97.

Recent Trading Activity for NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
Shares of NASDAQ:GILD – Gilead Sciences closed the previous trading session at 66.38 down -6.18 8.52% with 68.75 shares trading hands.